Detalles de la búsqueda
1.
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.
N Engl J Med
; 379(24): 2342-2350, 2018 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280658
2.
Preclinical evaluation of [225Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms.
Eur J Nucl Med Mol Imaging
; 48(11): 3408-3421, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33772332
3.
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
N Engl J Med
; 377(20): 1919-1929, 2017 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28885881
4.
Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study.
J Transl Med
; 18(1): 39, 2020 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32000810
5.
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Lancet Oncol
; 20(12): 1670-1680, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601496
6.
Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance.
Br J Cancer
; 120(8): 791-796, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30880334
7.
Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.
Cancer Immunol Immunother
; 68(3): 517-527, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30591959
8.
Loneliness as a mediator of the relationship of social cognitive variables with depressive symptoms and quality of life in lung cancer patients beginning treatment.
Psychooncology
; 28(6): 1234-1242, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30932275
9.
A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma.
Cancer Immunol Immunother
; 67(12): 1853-1862, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30209589
10.
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial.
Lancet Oncol
; 17(2): 234-242, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26708155
11.
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.
Oncologist
; 21(10): 1163-1164, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27694157
12.
Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis.
Cancer Control
; 23(1): 61-6, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27009459
13.
Propelling Immunotherapy Combinations Into the Clinic.
Oncology (Williston Park)
; 29(12): 990-1002, 2015 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26680224
14.
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.
Lancet Oncol
; 15(10): 1119-28, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25153538
15.
Advanced EGFR mutation-positive non-small-cell lung cancer: case report, literature review, and treatment recommendations.
Cancer Control
; 21(1): 67-73, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24357744
16.
Current clinical application of genomic and proteomic profiling in non-small-cell lung cancer.
Cancer Control
; 21(1): 32-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24357739
17.
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer.
Cancer Immunol Immunother
; 62(5): 909-18, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23589106
18.
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors.
J Transl Med
; 11: 62, 2013 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-23497415
19.
Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer.
Cancer Control
; 20(1): 22-31, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23302904
20.
Treatment Strategies for Non-Small Cell Lung Cancer with Common EGFR Mutations: A Review of the History of EGFR TKIs Approval and Emerging Data.
Cancers (Basel)
; 15(3)2023 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765587